Tag: Orange Book
How Paragraph IV Patent Challenges Speed Up Generic Drug Entry
Paragraph IV under the Hatch-Waxman Act lets generic drug makers challenge brand patents to speed up affordable drug access. It’s how most generic drugs enter the market-and why prices drop so sharply.
Read more
Generic Patent Case Law: Landmark Court Decisions That Shape Drug Access
Landmark court decisions in generic patent law shape whether affordable drugs reach patients. Key rulings like Amgen v. Sanofi and Allergan v. Teva are redefining how patents are challenged and enforced in the pharmaceutical industry.
Read more